Protective effect of Azadirachta indica A. Juss against doxorubicin-induced cardiac toxicity in tumour bearing mice

Indian Journal of Experimental Biology

Volumn 52, Issue 4, 2014, Pages 323-331

  Koul, Ashwani ^a   Goyal, Renu ^a   Bharati, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Azadirachta indica; Cardiac toxicity; Doxorubicin; Oxidative stress; Tumour

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CARDIOTONIC AGENT; DOXORUBICIN; PLANT EXTRACT;

ANIMAL; ARTICLE; AZADIRACHTA INDICA; BAGG ALBINO MOUSE; CELL PROTECTION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; HEART DISEASE; HEART MUSCLE CELL; MALE; MOUSE; NEOPLASM;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AZADIRACHTA; CARDIOTONIC AGENTS; CYTOPROTECTION; DOXORUBICIN; HEART DISEASES; MALE; MICE; MICE, INBRED BALB C; MYOCYTES, CARDIAC; NEOPLASMS; PLANT EXTRACTS;

EID: 84898415956     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Minotti G, Menna P, Salvatorelli E, Cairo G & Gianni L, Anthracyclines: Molecular advances and pharmacologie developments in antitumour activity and cardiotoxicity, Pharmacol Rev, 56 (2004) 185.
2. Bernstein D, Fajardo G, Zhao M, Urashima T, Powers J, Berry G & Kobilka B K, Differential cardioprotective/cardiotoxic effects mediated by beta adrenergic receptor subtypes, Am J Physiol Heart Circ Physiol, 289 (2005) H 2441.
3. Ghibu S, Delemasure S, Richard C, Guilland J C, Martin L, Gambert S, Rochette L & Vergely C, General oxidative stress during doxorubicin-induced cardiotoxicity in rats: Absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid, Biochimie, 94 (2012) 932.
4. Doroshow J H & Davies K J A, Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical, J Biol Chem, 261 (1986) 3068.
5. Chen B, Peng X, Pentassuglia L, Lim C C & Sawyer D B, Molecular and cellular mechanisms of anthracycline cardiotoxicity, Cardiovasc Toxicol, 7 (2007) 114.
6. Grankvist K, Stendahl U & Henriksson R, Comparative Study of Demethoxydaunorubicin with other anthracyclines on generation of oxygen radicals and clonogenic survival of fibroblasts, Pharmacol Toxicol, 65 (1989) 40.
7. Castellani R J, Moreira P I, Perry G & Zhu X, The role of iron as a mediator of oxidative stress in Alzheimer disease, Biofactors, 38 (2012) 133.
8. Singal P K, Iliskovic N, Li T & Kumar D, Adriamycin cardiomyopathy: pathophysiology and prevention, FASEB J, 12 (1997) 931.
9. El-Missiry M A, Othman AI, Amer M A & Abd El-Aziz M A, Attenuation of the acute Adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats, Free Radic Res, 35 (2001) 575.
10. Lipshultz S E, Rifai N, Dalton V M, Levy D E, Silverman L B, Lipsitz S R, Colan W S D, Asselin B L, Clavell L A, Hurwitz C A, Moghrabi R D, Samson Y, Schorin M A, Gelber R D & Sallan S E, The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia, N Engl J Med, 351 (2004) 145.
11. Singal P K, Siveski-Iliskovic N, Hill M, Thomas P T, & Li T, Combination therapy with probucol prevents Adriamycininduced cardiomyopathy, J Mol Cell Cardiol, 27 (1995) 1055.
12. Berthiaume J M, Oliveira P J, Fariss M W, & Wallace K B, Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction, Cardiovasc Toxicol, 3 (2005) 257.
13. Van Vleet J F, Ferrans V J & Weirich W E, Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants, Am J Pathol, 99 (1980) 13.
14. Seifert C F & Nesser M E, Thompson D F, Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity, Ann Pharmacother, 28 (1994) 1063.
15. Kruger A & Wojnowski L, Cardiotoxicity of anthracyclines - an Unsolved problem, Dtsch Arztebl Int, 37 (2006) A-2393.
16. Obiefuna I & Young R, Concurrent administration of aqueous Azadirachta indica (neem) leaf extract with DOCA-salt prevents the development of hypertension and accompanying electrocardiogram changes in the rat, Phytother Res, 19 (2005) 792.
17. Koley K M & Lal J, Pharmacological effects of Azadirachta indica (neem) leaf extract on the ECG and blood pressure of rat, Indian J Physiol Pharmacol, 38 (1994) 223.
18. Peer P A, Trivedi P C, Nigade P B, Ghaisas M M & Deshpande A D, Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats, Int J Cardiol, 126 (2008) 123.
19. Imam H, Hussain A & Ajij A, Neem (Azadirachta indica A. Juss) - A Nature's drugstore: An overview, I. Res. J. Biological Sci, 1 (2012) 76.
20. Das B K, Mukherjee S C, Sahu B B & Murjani G, Neem (Azadirachta indica) extract as an antibacterial agent against fish pathogenic bacteria, Indian J Exp Biol, 37 (1999) 1097.
21. Biswas K, Chattopadhyay I, Banerjee R K & Bandyopadhyay U, Biological activities and medicinal properties of neem (Azadirachta indica), Curr Sci, 11 (2002) 1336.
22. Ray A, Banerjee B D & Sen P, Modulation of humoral and cell-mediated immune response by Azadirachta indica (Neem) in mice, Indian J Exp Biol, 34 (1996) 698.
23. Koul A, Binepal G & Gangar S C, Impediment of diethylnitrosamine induced hepatotoxicity in male Balb/c mice by pretreatment with aqueous Azadirachta indica leaf extract, Indian J Exp Biol,4 (2007) 359.
24. Koul A, Kapoor N & Bharati S, Histopathological, enzymatic, and molecular alterations induced by cigarette smoke inhalation in the pulmonary tissue of mice and its amelioration by aqueous Azadirachta indica leaf extract, J Environl Pathol Toxicol Oncol,31 (2012) 7.
25. Bandyopadhyay U, Biswas K, Chatterjee R, Bandyopadhyay D, Chattopadhyay I, Ganguly C K, Chakraborty T, Bhattacharya K & Banerjee R K, Gastroprotective effect of Neem (Azadirachta indica) bark extract: Possible involvement of H+-K+-ATPase inhibition and scavenging of hydroxyl radical, Life Sci, 71 (2002) 2845.
26. Arora N, Koul A & Bansal M P, Chemopreventive activity of Azadirachta indica on two-stage skin carcinogenesis in murine model, Phytother Res, 25 (2011) 408.
27. Pereira-Junior P P, Marocolo M, Rodrigues F P, Medei E & Nascimento J H M, Noninvasive method for electrocardiogram recording in conscious rats: Feasibility for heart rate variability analysis, An Acad Bras Cienc, 82 (2010) 431.
28. Van Acker S A, Kramer K, Grimbergen J A, Van den Berg D J, Van der Vijgh W J & Bast A, Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity, Br J Pharmacol, 115 (1995) 1260.
29. Trush M A, Mimnaugh E G, Ginsburg E & Gram T E, In vitro stimulation by paraquat of reactive oxygen-mediated lipid peroxidation in rat lung microsomes, Toxicol Appl Pharmacol, 60 (1981) 279.
30. Moron M S, Depierre J W & Mannervik B, Levels of glutathione, glutathione reductase and glutathione-Stransferase activities in rat lung and liver, Biochim et Biophy Acta, 582 (1979) 67.
31. Kono Y, Generation of superoxide radical during autooxidation of hydroxylamine and assay for superoxide Dismutase, Arch Biochem Biophys, 186 (1978) 189.
32. Luck H, Catalase, in Methods of enzymatic analysis, edited by HU Bergmeyer, (Academic Press, New York) 1963, 885.
33. Paglia D E & Valentine W N, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J Lab Clin Med, 70 (1967) 158.
34. Carlberg I & Mannervik B, Purification and characterization of the flavo enzyme glutathione reductase from rat liver, J Biol Chem, 250 (1975) 5475.
35. Lowry O H, Rosebrough N J, Farr A L & Randell R J, Protein measurement with Folin phenol reagent, J Biol Chem, 193 (1951) 256.
36. Bharati S, Rishi P & Koul A, Azadirachta indica exhibits chemopreventive action against hepatic cancer: Studies on associated histopathological and ultrastructural changes, Microsc Res Tech, 75 (2012) 586.
37. Ghosh D, Bose A, Haque E & Baral R, Pretreatment with neem (Azadirachta indica) leaf preparation in Swiss mice diminishes leukopenia and enhances the antitumour activity of cyclophosphamide, Phytother Res, 20 (2006) 814.
38. Ghosh D, Bose A, Haque E & Baral R, Neem (Azadirachta indica) leaf preparation prevents leukocyte apoptosis mediated by cisplatin plus 5-fluorouracil treatment in Swiss mice, Chemotherapy, 55 (2009) 137.
39. Koul A, Ghara A R & Gangar S C, Chemomodulatory effects of Azadirachta indica on the hepatic status of skin tumour bearing mice, Phytother Res, 20 (2006) 169.
40. Hazari M S, Haykal-Coates N, Winsett D W, Costa D L & Farraj A K, Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar- Kyoto and spontaneously hypertensive rats to doxorubicin, Toxicol Sci, 110 (2009) 224.
41. Xin Y, Zhang S, Gu L, Liu S, Gao H, You Z, Zhou G, Wen L, Yu J & Xuan Y, Electrocardiographic and biochemical evidence for the cardioprotective effect of antioxidants in acute doxorubicin-induced cardiotoxicity in the beagle dogs, Biol Pharm Bull, 34 (2011) 1523.
42. Kelishomi R B, Ejtemaeemehr S, Tavangar S M, Rahimian R, Mobarakeh J I & Dehpour A R, Morphine is protective against doxorubicin induced cardiotoxicity in rats, Toxicology, 243 (2008) 96.
43. Puri A, Maulik S K, Ray R & Bhatnagar V, Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats, Eur J Pediatr Surg, 15 (2005) 387.
44. Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E & Kotamraju S, Doxorubicin-induced apoptosis: Implications in cardiotoxicity, Mol Cell Biochem, 234 (2002) 119.
45. Gujral J S, Bucci T J, Farhood A & Jaeschke H, Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis?, Hepatology, 33 (2001) 397.
46. Negre-Salvayre A, Coatrieux C, Ingueneau C & Salvayre R, Advanced lipid peroxidation end products in oxidative damage to proteins, Potential role in diseases and therapeutic prospects for the inhibitors, Br J Pharmacol, 153 (2008) 6.
47. 2; an explanation for the cardiotoxicity of anthracycline antibiotics, Biochem Biophy Res Commun, 114 (1983) 197.
48. Matés J M, Pérez-Gómez C & Núñez de Castro I, Antioxidant enzymes and human diseases, Clin Biochem, 32 (1999) 595.